LXP1788 Injection

LXP1788 · LaunXP Biomedical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LXP1788 Injection, covering 2025-03-19 to 2025-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. [Phase 1]